Shusted, Christine S.
Juon, Hee-Soon
Ruane, Brooke
Till, Brian
Zeigler-Johnson, Charnita
McIntire, Russell K.
Grenda, Tyler
Okusanya, Olugbenga
Evans, Nathaniel R.
Kane, Gregory C.
Barta, Julie A.
Funding for this research was provided by:
Prevent Cancer Foundation
Article History
Received: 10 November 2022
Accepted: 19 October 2023
First Online: 30 October 2023
Declarations
:
: This study – including the experimental protocol – was reviewed and approved by the Thomas Jefferson University Institutional Review Board (IRB) with a waiver of informed consent, given the minimal risk nature of the study (IRB Control#, 17D.150). This retrospective analysis was carried out in accordance with all methodological guidelines and regulations of the Thomas Jefferson University IRB, as well as the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.
: Not applicable.
: JB reports research grants from the Genentech Health Equity Innovations Fund outside the submitted work. The remaining authors declare that they have no competing interests.